FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990654889> ?p ?o ?g. }

• W1990654889 endingPage "711" @default.
• W1990654889 startingPage "706" @default.
• W1990654889 abstract "Summary Background Patients with severe refractory asthma have not achieved asthma control, even with high doses of ICS , usually in combination with LABA s and other maintenance treatments. Objective The most promising approaches currently under investigation are those which reduce airway eosinophils in patients with severe refractory asthma and a persisting airway eosinophilia. Results Monoclonal antibodies against IL ‐5 have been shown to improve lung function, improve asthma control, reduce exacerbation risk and allow reduction or elimination of maintenance oral corticosteroids in this subset of patients. Bronchial thermoplasty may provide benefit in improving control and reducing exacerbations in selected patients. The addition of the muscarinic antagonist, tiotropium also improves airflow obstruction, but its benefit on exacerbation risk is not yet established. Other developments being evaluated in severe refractory asthma are CXCR 2 antagonists in patients with a persisting neutrophilic airway inflammation, and CRTh 2 antagonists, both of which are small molecule antagonists, and hM abs against IL 4 and IL ‐13. Finally, other approaches to reduce receptor numbers, using inhaled anti‐sense, has shown to reduce allergen‐induced airway eosinophilia, and combining different anti‐sense against different targets may become a feasible treatment option. Conclusions A variety of new treatment options are being investigated to help improve overall asthma control in patients with severe refractory asthma. These include medications to optimize lung function; bronchial thermoplasty to reduce airway smooth muscle in central airways; and those which target specific inflammatory cells or receptors of inflammatory mediators. Clinical Relevance Patients with severe refractory asthma have the greatest unmet treatment needs to improve asthma control and reduce exacerbation risk. New treatment approaches have been identified which will benefit subsets of these patients. Phenotyping patients is necessary to select those likely to benefit." @default.
• W1990654889 created "2016-06-24" @default.
• W1990654889 creator A5018374796 @default.
• W1990654889 creator A5022431660 @default.
• W1990654889 creator A5081195905 @default.
• W1990654889 date "2012-04-20" @default.
• W1990654889 modified "2023-09-27" @default.
• W1990654889 title "Severe asthma: future treatments" @default.
• W1990654889 cites W1512168554 @default.
• W1990654889 cites W1557717457 @default.
• W1990654889 cites W1795103282 @default.
• W1990654889 cites W1916962812 @default.
• W1990654889 cites W1988758075 @default.
• W1990654889 cites W1991886932 @default.
• W1990654889 cites W1993997407 @default.
• W1990654889 cites W1994585625 @default.
• W1990654889 cites W2006174105 @default.
• W1990654889 cites W2022235585 @default.
• W1990654889 cites W2029251290 @default.
• W1990654889 cites W2031494108 @default.
• W1990654889 cites W2032110591 @default.
• W1990654889 cites W2037542404 @default.
• W1990654889 cites W2047359372 @default.
• W1990654889 cites W2062918919 @default.
• W1990654889 cites W2065801967 @default.
• W1990654889 cites W2067324660 @default.
• W1990654889 cites W2070348992 @default.
• W1990654889 cites W2084624382 @default.
• W1990654889 cites W2092222859 @default.
• W1990654889 cites W2096723137 @default.
• W1990654889 cites W2107207387 @default.
• W1990654889 cites W2110052844 @default.
• W1990654889 cites W2110882251 @default.
• W1990654889 cites W2112580075 @default.
• W1990654889 cites W2121195755 @default.
• W1990654889 cites W2123257822 @default.
• W1990654889 cites W2126325768 @default.
• W1990654889 cites W2127303736 @default.
• W1990654889 cites W2127482775 @default.
• W1990654889 cites W2136199835 @default.
• W1990654889 cites W2136576396 @default.
• W1990654889 cites W2149810044 @default.
• W1990654889 cites W2150035260 @default.
• W1990654889 cites W2150634254 @default.
• W1990654889 cites W2154263136 @default.
• W1990654889 cites W2156797817 @default.
• W1990654889 cites W2157566717 @default.
• W1990654889 cites W2162269447 @default.
• W1990654889 cites W2164092307 @default.
• W1990654889 cites W2166893697 @default.
• W1990654889 cites W2171776700 @default.
• W1990654889 cites W2315018741 @default.
• W1990654889 cites W2331287401 @default.
• W1990654889 cites W2956481022 @default.
• W1990654889 doi "https://doi.org/10.1111/j.1365-2222.2012.03965.x" @default.
• W1990654889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22515391" @default.
• W1990654889 hasPublicationYear "2012" @default.
• W1990654889 type Work @default.
• W1990654889 sameAs 1990654889 @default.
• W1990654889 citedByCount "64" @default.
• W1990654889 countsByYear W19906548892012 @default.
• W1990654889 countsByYear W19906548892013 @default.
• W1990654889 countsByYear W19906548892014 @default.
• W1990654889 countsByYear W19906548892015 @default.
• W1990654889 countsByYear W19906548892016 @default.
• W1990654889 countsByYear W19906548892017 @default.
• W1990654889 countsByYear W19906548892018 @default.
• W1990654889 countsByYear W19906548892019 @default.
• W1990654889 countsByYear W19906548892020 @default.
• W1990654889 countsByYear W19906548892021 @default.
• W1990654889 countsByYear W19906548892022 @default.
• W1990654889 countsByYear W19906548892023 @default.
• W1990654889 crossrefType "journal-article" @default.
• W1990654889 hasAuthorship W1990654889A5018374796 @default.
• W1990654889 hasAuthorship W1990654889A5022431660 @default.
• W1990654889 hasAuthorship W1990654889A5081195905 @default.
• W1990654889 hasConcept C105922876 @default.
• W1990654889 hasConcept C121332964 @default.
• W1990654889 hasConcept C142424586 @default.
• W1990654889 hasConcept C203014093 @default.
• W1990654889 hasConcept C2776042228 @default.
• W1990654889 hasConcept C2776550738 @default.
• W1990654889 hasConcept C2777014857 @default.
• W1990654889 hasConcept C2777129736 @default.
• W1990654889 hasConcept C33362165 @default.
• W1990654889 hasConcept C42219234 @default.
• W1990654889 hasConcept C71924100 @default.
• W1990654889 hasConcept C87355193 @default.
• W1990654889 hasConceptScore W1990654889C105922876 @default.
• W1990654889 hasConceptScore W1990654889C121332964 @default.
• W1990654889 hasConceptScore W1990654889C142424586 @default.
• W1990654889 hasConceptScore W1990654889C203014093 @default.
• W1990654889 hasConceptScore W1990654889C2776042228 @default.
• W1990654889 hasConceptScore W1990654889C2776550738 @default.
• W1990654889 hasConceptScore W1990654889C2777014857 @default.
• W1990654889 hasConceptScore W1990654889C2777129736 @default.
• W1990654889 hasConceptScore W1990654889C33362165 @default.
• W1990654889 hasConceptScore W1990654889C42219234 @default.

• next